Clinical trial NCT04065191: Workplace HIIT: Feasibility and Preventive Effects of HIIT in the Real-World
Official title: High-intensity Interval Training for Workplace Health Promotion: Evaluation of Feasibility and Preventive Effects in a Real-World Setting
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: NA
Conditions: Primary Prevention
Health Promotion
Keywords: Aerobic exercise
Cardiorespiratory Fitness
High-intensity interval training (HIIT)
Workability
Prevention
Lead sponsor: University of Erlangen-Nürnberg Medical School
Sponsor class: OTHER
First posted: 2019-08-22
Enrollment: 300
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: NA
Intervention model: SINGLE_GROUP
Primary purpose: PREVENTION

Brief summary: The aim of this study is to investigate the effects of an extremely time-efficient high-intensity interval training program, performed over a period of six months in a real-world (workplace) setting, on cardiorespiratory fitness, cardiometabolic risk profile, and self-reported outcomes including perceived stress and subjective work ability in previously sedentary employees.


Eligibility criteria: Inclusion Criteria:

* Sedentary Lifestyle over at least 1 year prior to the study

Exclusion Criteria:

* Pregnancy, Lactation
* Psychological disorders, epilepsy, sever neurological disorders
* Participation in other exercise- or nutrition studies within the last 6 months
* coronary heart disease, heart failure
* malignant disease
* severe rheumatic or neurological disease
* severe/unstable hypertension (resting RR: \>180/\>110 mmHg)
* severely restricted lung function (FEV1 \<60%)
* unstable Diabetes mellitus
* severe orthopedic disease/restriction
* acute / chronic infectious diseases
* Electronic implants (defibrillator, pacemaker)
* Persons in mental hospitals by order of authorities or jurisdiction

Primary outcomes:
measure: Cardiorespiratory Fitness (CRF)
timeFrame: 12 months [Change from Baseline to 6 months and Change from Baseline to 6 months after the end of the intervention]
Secondary outcomes:
measure: Metabolic Syndrome Z-Score (MetS-Z-Score)
timeFrame: 12 months [Change from Baseline to 6 months and Change from Baseline to 6 months after the end of the intervention]
measure: Muscle mass
timeFrame: 12 months [Change from Baseline to 6 months and Change from baseline to 6 months after the end of the intervention]
measure: Fat mass
timeFrame: 12 months [Change from baseline to 6 months and change from baseline to 6 months after the end of the intervention]
measure: Total body water
timeFrame: 12 months [Change from baseline to 6 months and change from baseline to 6 months after the end of the intervention]
measure: Insulin sensitivity
timeFrame: 12 months [Change from Baseline to 6 months and Change from Baseline to 6 months after the end of the intervention]
measure: Inflammation status
timeFrame: 12 months [Change from Baseline to 6 months and Change from Baseline to 6 months after the end of the intervention]
measure: Health-related quality of life
timeFrame: 12 months [Change from Baseline to 6 months and Change from Baseline to 6 months after the end of the intervention]
measure: Pain scores
timeFrame: 12 months [Change from Baseline to 6 months and Change from Baseline to 6 months after the end of the intervention]
measure: Perceived stress
timeFrame: 12 months [Change from Baseline to 6 months and Change from Baseline to 6 months after the end of the intervention]
measure: Subjective work ability
timeFrame: 12 months [Change from Baseline to 6 months and Change from Baseline to 6 months after the end of the intervention]
Other outcomes:
Locations:
city: Erlangen
country: Germany
facility: Department of Medicine 1, Hector Center for Nutrition, Exercise and Sports, Friedrich-Alexander-University Erlangen-Nuremberg
Study officials:
affiliation: University Erlangen Nuremberg Medical School
name: Dejan Reljic, Dr.
role: PRINCIPAL_INVESTIGATOR
affiliation: University Erlangen Nuremberg Medical School
name: Yurdaguel Zopf, Prof.
role: PRINCIPAL_INVESTIGATOR
References: